• Most Popular
  • Most Shared

Marshall Edwards: Triphendiol gets additional orphan drug status

Tue Feb 19, 2008 8:02am EST

Stocks

   

Feb 19 (Reuters) - Marshall Edwards Inc (MSHL.O) said its experimental cancer drug triphendiol was granted an orphan drug status by the U.S. Food and Drug Administration for treatment of malignant melanoma.

Stocks  |  Regulatory News

Triphendiol also has an orphan drug status for the treatment of pancreatic cancer and for the treatment of cholangiocarcinoma, bile duct cancer.

An orphan drug refers to a product that is intended for use in a disease or condition that affects fewer than 200,000 individuals in the United States. (Reporting by Jennifer Robin Raj in Bangalore; Editing by Amitha Rajan)

Stocks
Regulatory News


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets